UK’s medicines and medical devices regulator to tackle Brexit, technological advancements and regulatory challenges (including from COVID-19) in 2020 and 2021
The MHRA has established five strategic goals for 2020-21 that will impact all those operating in the UK medicines and medical devices industries
The EU has published further details on its Sustainable Products Initiative, one of the measures announced in the new Circular Economy Action Plan.
See EU later – the UK government has issued guidance on placing manufactured goods on the market in post-Brexit Great Britain and using the UKCA mark from 1 January 2021
Here’s our snap review of the guidance issued today…
Cooley’s international products law team are pleased to announce the fifth event in its webinar series, together with experts from Compliance & Risks and Ramboll. As an area of major regulatory and business change for product manufacturers, suppliers and other stakeholders, we anticipate the impact of the move towards the […]